Orteq company
Orteq was established in 2005 to develop and commercialize bioengineering solutions for orthopaedic injuries. Orteq has developed a biodegradable, biocompatible polymer implant, Actifit, specifically designed to promote tissue ingrowth and regeneration in the meniscus, a fibrocartilage cushion in the knee. The company develops innovative healthcare products for the arthroscopic sports medicine surgeon that encourage the bodyвАЩs own natural healing process. Orteq is headquartered in London.
Total Funding:
£8M
Headquarters:
London, England, United Kingdom
Employee Number:
501-1000
Estimated Revenue:
$1M to $10M
Last Funding Type:
Undisclosed
Technology:
Regenerative Medicine
Investor Type:
For Profit
Investors Number:
2
Founded Date:
2005-01-01
Industry:
Biotechnology, Health Care, Manufacturing, Science and Engineering, Sports